Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
295.56
+0.34 (0.12%)
At close: Jun 16, 2025, 4:00 PM
294.21
-1.35 (-0.46%)
After-hours: Jun 16, 2025, 7:48 PM EDT

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of $158.92 billion. The enterprise value is $207.50 billion.

Market Cap 158.92B
Enterprise Value 207.50B

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, after market close.

Earnings Date Aug 5, 2025
Ex-Dividend Date May 16, 2025

Share Statistics

Amgen has 537.71 million shares outstanding. The number of shares has increased by 0.88% in one year.

Current Share Class 537.71M
Shares Outstanding 537.71M
Shares Change (YoY) +0.88%
Shares Change (QoQ) -0.18%
Owned by Insiders (%) 0.15%
Owned by Institutions (%) 81.53%
Float 536.33M

Valuation Ratios

The trailing PE ratio is 27.01 and the forward PE ratio is 14.28. Amgen's PEG ratio is 2.80.

PE Ratio 27.01
Forward PE 14.28
PS Ratio 4.66
Forward PS 4.43
PB Ratio 25.60
P/TBV Ratio n/a
P/FCF Ratio 14.56
P/OCF Ratio 13.04
PEG Ratio 2.80
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.19, with an EV/FCF ratio of 19.01.

EV / Earnings 34.97
EV / Sales 6.08
EV / EBITDA 13.19
EV / EBIT 20.21
EV / FCF 19.01

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 9.24.

Current Ratio 1.17
Quick Ratio 0.74
Debt / Equity 9.24
Debt / EBITDA 3.60
Debt / FCF 5.26
Interest Coverage 2.88

Financial Efficiency

Return on equity (ROE) is 105.67% and return on invested capital (ROIC) is 9.67%.

Return on Equity (ROE) 105.67%
Return on Assets (ROA) 7.04%
Return on Invested Capital (ROIC) 9.67%
Return on Capital Employed (ROCE) 15.47%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.37
Inventory Turnover 1.37

Taxes

In the past 12 months, Amgen has paid $717.00 million in taxes.

Income Tax 717.00M
Effective Tax Rate 10.78%

Stock Price Statistics

The stock price has decreased by -1.02% in the last 52 weeks. The beta is 0.50, so Amgen's price volatility has been lower than the market average.

Beta (5Y) 0.50
52-Week Price Change -1.02%
50-Day Moving Average 282.14
200-Day Moving Average 296.51
Relative Strength Index (RSI) 62.04
Average Volume (20 Days) 2,531,054

Short Selling Information

The latest short interest is 12.94 million, so 2.41% of the outstanding shares have been sold short.

Short Interest 12.94M
Short Previous Month 14.36M
Short % of Shares Out 2.41%
Short % of Float 2.41%
Short Ratio (days to cover) 4.11

Income Statement

In the last 12 months, Amgen had revenue of $34.13 billion and earned $5.93 billion in profits. Earnings per share was $10.94.

Revenue 34.13B
Gross Profit 23.57B
Operating Income 10.27B
Pretax Income n/a
Net Income 5.93B
EBITDA 15.73B
EBIT 10.27B
Earnings Per Share (EPS) $10.94
Full Income Statement

Balance Sheet

The company has $8.81 billion in cash and $57.38 billion in debt, giving a net cash position of -$48.57 billion or -$90.33 per share.

Cash & Cash Equivalents 8.81B
Total Debt 57.38B
Net Cash -48.57B
Net Cash Per Share -$90.33
Equity (Book Value) 6.21B
Book Value Per Share 11.54
Working Capital 3.92B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $12.19 billion and capital expenditures -$1.28 billion, giving a free cash flow of $10.92 billion.

Operating Cash Flow 12.19B
Capital Expenditures -1.28B
Free Cash Flow 10.92B
FCF Per Share $20.30
Full Cash Flow Statement

Margins

Gross margin is 69.07%, with operating and profit margins of 30.08% and 17.39%.

Gross Margin 69.07%
Operating Margin 30.08%
Pretax Margin 19.49%
Profit Margin 17.39%
EBITDA Margin 46.08%
EBIT Margin 30.08%
FCF Margin 31.98%

Dividends & Yields

This stock pays an annual dividend of $9.52, which amounts to a dividend yield of 3.22%.

Dividend Per Share $9.52
Dividend Yield 3.22%
Dividend Growth (YoY) 5.71%
Years of Dividend Growth 14
Payout Ratio 87.00%
Buyback Yield -0.88%
Shareholder Yield 2.34%
Earnings Yield 3.73%
FCF Yield 6.87%
Dividend Details

Analyst Forecast

The average price target for Amgen is $323.62, which is 9.49% higher than the current price. The consensus rating is "Buy".

Price Target $323.62
Price Target Difference 9.49%
Analyst Consensus Buy
Analyst Count 21
Revenue Growth Forecast (5Y) 3.00%
EPS Growth Forecast (5Y) 26.27%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 22, 1999. It was a forward split with a ratio of 2:1.

Last Split Date Nov 22, 1999
Split Type Forward
Split Ratio 2:1

Scores

Amgen has an Altman Z-Score of 1.56 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.56
Piotroski F-Score 6